Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-267665
Filing Date
2026-06-11
Accepted
2026-06-11 16:30:27
Documents
1
Period of Report
2026-06-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4550
  Complete submission text file 0001193125-26-267665.txt   6159
Mailing Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA
Business Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address
Harwin Peter Evan (Reporting) CIK: 0001663607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 261083543